News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal
Photo from V. Lokesh Battula/LinkedIn
Dec 1, 2023, 19:13

V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal

V. Lokesh Battula, Associate Professor at MD Anderson Cancer Center, shared on LinkedIn:

“Happy to report that our findings on resistance to FLT3 inhibitors in AML are now published in the Leukemia Journal. In this report, we have reported ACVR1 as a novel resistance factor for FLT3 inhibitors in AML and introduced a novel FLT3-ACVR1 dual inhibitor (TP-0184) as a single agent to target both FLT3 and its resistance factor in AML!”

V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal

Read the article here.
Source: V. Lokesh Battula/LinkedIn

AML cancer FLT3 inhibitors Leukemia Journal OncoDaily Oncology publication V. Lokesh Battula
Special Coverage
Blog
Feb 22, 2025, 04:19
Secure your spot for the CCI4EU Online Course by ESO
Blog
Feb 22, 2025, 04:16
Manchester Cancer Research Centre will continue its leadership in early detection science following the renewal of ACED
Blog
Feb 22, 2025, 04:12
Citrus Oncology is part of the 14 startups selected for the 2025 CancerX Accelerator
Science
Feb 22, 2025, 04:08
Anticancer potential of NO-Donor Oxadiazole in malignant pleural mesothelioma - The Babak Lab
Blog
Feb 22, 2025, 03:56
Early bird registration deadline for the 15th CCI Europe Conference approaches
Blog
Feb 22, 2025, 03:52
Share Your MASCC Guidelines Experience
Insight
Feb 22, 2025, 03:44
George Vlachogiannis: Cutting cancer mortality in Canada by 50% by 2050 - can we get there?
Blog
Feb 22, 2025, 03:21
Brian Kim: Unsolicited advice to new PIs
Blog
Feb 22, 2025, 03:18
Christine Lovly: Why is NIH important?
Blog
Feb 22, 2025, 02:53
Wafaa M Rashed: Empowering Voices in Genetics and Genomics Advocacy with Deborah Ekusai Sebatta
Blog
Feb 22, 2025, 02:50
Danielle Bitterman Calls on Conference Leaders to Provide Hybrid Options for HHS-Funded Scientists
Blog
Feb 22, 2025, 02:44
United by Unique Showcase Event - Manchester Cancer Research Centre